Blood disorders after kidney transplantation
Tóm tắt
Từ khóa
Tài liệu tham khảo
Malyszko, 2012, Anemia and erythrocytosis in patients after kidney transplantation, Transplant international: official journal of the European Society for Organ Transplantation, 25, 1013, 10.1111/j.1432-2277.2012.01513.x
Malyszko, 2012, Anemia in solid organ transplantation, Annals of transplantation: quarterly of the Polish Transplantation Society, 17, 86, 10.12659/AOT.883227
Yabu, 2011, Posttransplantation anemia: mechanisms and management, Clinical journal of the American Society of Nephrology: CJASN, 6, 1794, 10.2215/CJN.01190211
Marinella, 2010, Hematologic abnormalities following renal transplantation, International urology and nephrology, 42, 151, 10.1007/s11255-009-9558-5
Smith, 2010, Hematologic disorders after solid organ transplantation, Hematology/the Education Program of the American Society of Hematology American Society of Hematology Education Program, 2010, 281, 10.1182/asheducation-2010.1.281
Heinze, 2009, Mortality in renal transplant recipients given erythropoietins to increase haemoglobin concentration: cohort study, Bmj, 339, b4018, 10.1136/bmj.b4018
Vanrenterghem, 2003, Prevalence and management of anemia in renal transplant recipients: a European survey, American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 3, 835, 10.1034/j.1600-6143.2003.00133.x
Molnar, 2011, Prevalence and management of anaemia in renal transplant recipients: data from ten European centres, Nephron Clinical practice, 117, c127, 10.1159/000319660
Jones, 2012, Anemia after kidney transplantation; its prevalence, risk factors, and independent association with graft and patient survival: a time-varying analysis, Transplantation, 93, 923, 10.1097/TP.0b013e31824b36fa
Mix, 2003, Anemia: a continuing problem following kidney transplantation, American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 3, 1426, 10.1046/j.1600-6135.2003.00224.x
2012, KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease, Kidney Int Suppl, 2, 279, 10.1038/kisup.2012.37
Ourahma, 2007, Anemia in the period immediately following renal transplantation, Transplant Proc, 39, 1446, 10.1016/j.transproceed.2006.12.036
Besarab, 1987, Dynamics of erythropoiesis following renal transplantation, Kidney international, 32, 526, 10.1038/ki.1987.241
Poesen, 2011, Prevalence and determinants of anemia in the immediate postkidney transplant period, Transplant international: official journal of the European Society for Organ Transplantation, 24, 1208, 10.1111/j.1432-2277.2011.01340.x
Zheng, 2009, Iron deficiency anemia and iron losses after renal transplantation, Transplant international: official journal of the European Society for Organ Transplantation, 22, 434, 10.1111/j.1432-2277.2008.00814.x
Sun, 1989, Serum erythropoietin levels after renal transplantation, N Engl J Med, 321, 151, 10.1056/NEJM198907203210304
Karthikeyan, 2004, The burden of chronic kidney disease in renal transplant recipients, American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 4, 262, 10.1046/j.1600-6143.2003.00315.x
Vanrenterghem, 2004, Anaemia after renal transplantation, Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association – European Renal Association, 19, V54, 10.1093/ndt/gfh1057
Chadban, 2007, Anemia after kidney transplantation is not completely explained by reduced kidney function, American journal of kidney diseases: the official journal of the National Kidney Foundation, 49, 301, 10.1053/j.ajkd.2006.11.034
Imoagene-Oyedeji, 2006, Posttransplantation anemia at 12months in kidney recipients treated with mycophenolate mofetil: risk factors and implications for mortality, Journal of the American Society of Nephrology: JASN, 17, 3240, 10.1681/ASN.2006010027
Kamar, 2008, Negative impact of one-year anemia on long-term patient and graft survival in kidney transplant patients receiving calcineurin inhibitors and mycophenolate mofetil, Transplantation, 85, 1120, 10.1097/TP.0b013e31816a8a1f
Winkelmayer, 2006, A prospective study of anaemia and long-term outcomes in kidney transplant recipients, Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association – European Renal Association, 21, 3559, 10.1093/ndt/gfl457
Molnar, 2007, Anemia is associated with mortality in kidney-transplanted patients – a prospective cohort study, American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 7, 818, 10.1111/j.1600-6143.2006.01727.x
Shibagaki, 2004, Anaemia is common after kidney transplantation, especially among African Americans, Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association – European Renal Association, 19, 2368, 10.1093/ndt/gfh256
Lorenz, 2002, Anemia and iron deficiencies among long-term renal transplant recipients, Journal of the American Society of Nephrology: JASN, 13, 794, 10.1681/ASN.V133794
Jimeno, 2005, Iron deficiency – an underrecognized problem in nonanemic and erythrocytic kidney transplant recipients: risks and effects of ACEI and of iron treatment, Transplantation proceedings, 37, 1007, 10.1016/j.transproceed.2004.11.081
Eid, 2006, Parvovirus B19 infection after transplantation: a review of 98 cases, Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 43, 40, 10.1086/504812
Geetha, 2000, Pure red cell aplasia caused by Parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature, Clinical transplantation, 14, 586, 10.1034/j.1399-0012.2000.140612.x
Garewal, 2004, Parvovirus B19 infection-associated red-cell aplasia in renal-transplant recipients: clues from the bone marrow, Transplantation, 77, 320, 10.1097/01.TP.0000092957.49621.37
Cohen, 1988, The prevalence of antibody to human parvovirus B19 in England and Wales, J Med Microbiol, 25, 151, 10.1099/00222615-25-2-151
Waldman, 2007, Parvovirus B19 and the kidney, Clinical journal of the American Society of Nephrology: CJASN, 2, S47, 10.2215/CJN.01060307
Capenko, 2012, Anemia as a complication of parvovirus b19 infection in renal transplant recipients, Medicina, 48, 299, 10.3390/medicina48060044
Crabol, 2013, Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature, Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 56, 968, 10.1093/cid/cis1046
Gosset, 2012, How many times can parvovirus B19-related anemia recur in solid organ transplant recipients?, Transplant infectious disease: an official journal of the Transplantation Society, 14, E64, 10.1111/j.1399-3062.2012.00773.x
Liefeldt, 2002, Eradication of parvovirus B19 infection after renal transplantation requires reduction of immunosuppression and high-dose immunoglobulin therapy, Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association, 17, 1840, 10.1093/ndt/17.10.1840
Shah, 2006, Posttransplantation anemia in adult renal allograft recipients: prevalence and predictors, Transplantation, 81, 1112, 10.1097/01.tp.0000205174.97275.b5
Winkelmayer, 2004, Pharmacoepidemiology of anemia in kidney transplant recipients, Journal of the American Society of Nephrology: JASN, 15, 1347, 10.1097/01.ASN.0000125551.59739.2E
Khosroshahi, 2006, Effects of azathioprine and mycophenolate mofetil-immunosuppressive regimens on the erythropoietic system of renal transplant recipients, Transplantation proceedings, 38, 2077, 10.1016/j.transproceed.2006.06.043
Zazgornik, 1997, Azathioprine induced macrocytosis and red cell aplasia in renal transplant patients, Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association, 12, 628, 10.1093/ndt/12.3.628a
Kuypers, 2008, Current target ranges of mycophenolic acid exposure and drug-related adverse events: a 5-year, open-label, prospective, clinical follow-up study in renal allograft recipients, Clinical therapeutics, 30, 673, 10.1016/j.clinthera.2008.04.014
Jacobson, 2011, Genetic determinants of mycophenolate-related anemia and leukopenia after transplantation, Transplantation, 91, 309, 10.1097/TP.0b013e318200e971
Augustine, 2004, Comparative effects of sirolimus and mycophenolate mofetil on erythropoiesis in kidney transplant patients, American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 4, 2001, 10.1111/j.1600-6143.2004.00612.x
Friend, 2007, Incidence of anemia in sirolimus-treated renal transplant recipients: the importance of preserving renal function, Transplant international: official journal of the European Society for Organ Transplantation, 20, 754, 10.1111/j.1432-2277.2007.00506.x
Fishbane, 2009, Posttransplant anemia: the role of sirolimus, Kidney international, 76, 376, 10.1038/ki.2009.231
Webster, 2006, Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials, Transplantation, 81, 1234, 10.1097/01.tp.0000219703.39149.85
Kim, 2006, Marked erythrocyte microcytosis under primary immunosuppression with sirolimus, Transplant international: official journal of the European Society for Organ Transplantation, 19, 12, 10.1111/j.1432-2277.2005.00190.x
Augustine, 2008, Reduction in erythropoietin resistance after conversion from sirolimus to enteric coated mycophenolate sodium, Transplantation, 86, 548, 10.1097/TP.0b013e3181814a96
Thaunat, 2005, Anemia after late introduction of sirolimus may correlate with biochemical evidence of a chronic inflammatory state, Transplantation, 80, 1212, 10.1097/01.tp.0000179106.07382.6a
Sofroniadou, 2010, Anaemia, microcytosis and sirolimus – is iron the missing link?, Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association – European Renal Association., 25, 1667, 10.1093/ndt/gfp674
Sanchez Fructuoso, 2007, Study of anemia after late introduction of everolimus in the immunosuppressive treatment of renal transplant patients, Transplantation proceedings, 39, 2242, 10.1016/j.transproceed.2007.06.032
Carson, 2012, Tacrolimus-induced thrombotic microangiopathy: natural history of a severe, acute vasculopathy, Clin Nephrol, 77, 79, 10.5414/CN107036
Elimelakh, 2007, Red cell aplasia and autoimmune hemolytic anemia following immunosuppression with alemtuzumab, mycophenolate, and daclizumab in pancreas transplant recipients, Haematologica, 92, 1029, 10.3324/haematol.10733
Ruggenenti, 2006, Basiliximab combined with low-dose rabbit anti-human thymocyte globulin: a possible further step toward effective and minimally toxic T cell-targeted therapy in kidney transplantation, Clinical journal of the American Society of Nephrology: CJASN, 1, 546, 10.2215/CJN.01841105
Vincenti, 2010, A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study), American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 10, 535, 10.1111/j.1600-6143.2009.03005.x
Marathias, 2004, Hematocrit-lowering effect following inactivation of renin-angiotensin system with angiotensin converting enzyme inhibitors and angiotensin receptor blockers, Current topics in medicinal chemistry, 4, 483, 10.2174/1568026043451311
Naik, 2008, Dapsone-induced hemolytic anemia in lung allograft recipients, The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation, 27, 1198, 10.1016/j.healun.2008.07.025
Ponticelli, 2002, Role of anaemia in cardiovascular mortality and morbidity in transplant patients, Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association, 17, 41, 10.1093/ndt/17.suppl_1.41
Kasiske, 2000, Cardiovascular disease after renal transplantation, Seminars in nephrology, 20, 176
Rigatto, 2003, Electrocardiographic left ventricular hypertrophy in renal transplant recipients: prognostic value and impact of blood pressure and anemia, Journal of the American Society of Nephrology: JASN, 14, 462, 10.1097/01.ASN.0000043141.67989.39
Rigatto, 2002, Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease, Journal of the American Society of Nephrology: JASN, 13, 1084, 10.1681/ASN.V1341084
Djamali, 2003, Increasing hematocrit reduces early posttransplant cardiovascular risk in diabetic transplant recipients, Transplantation, 76, 816, 10.1097/01.TP.0000084872.26360.C5
Kovesdy, 2006, Association of anemia with outcomes in men with moderate and severe chronic kidney disease, Kidney Int, 69, 560, 10.1038/sj.ki.5000105
Xia, 1999, Hematocrit levels and hospitalization risks in hemodialysis patients, Journal of the American Society of Nephrology: JASN, 10, 1309, 10.1681/ASN.V1061309
Kolonko, 2009, Anemia and erythrocytosis after kidney transplantation: a 5-year graft function and survival analysis, Transplantation proceedings, 41, 3046, 10.1016/j.transproceed.2009.07.090
Chhabra, 2008, Impact of anemia after renal transplantation on patient and graft survival and on rate of acute rejection, Clinical journal of the American Society of Nephrology: CJASN, 3, 1168, 10.2215/CJN.04641007
Ott, 2008, Anemia after renal transplantation: an underestimated problem, Transplant Proc, 40, 3481, 10.1016/j.transproceed.2008.07.139
Vanrenterghem, 2008, Risk factors for cardiovascular events after successful renal transplantation, Transplantation, 85, 209, 10.1097/TP.0b013e318160254f
Gheith, 2009, Does posttransplant anemia at 6months affect long-term outcome of live-donor kidney transplantation? A single-center experience, Clinical and experimental nephrology, 13, 361, 10.1007/s10157-009-0171-9
Moore, 2008, The impact of hemoglobin levels on patient and graft survival in renal transplant recipients, Transplantation, 86, 564, 10.1097/TP.0b013e318181e276
Akbari, 2007, Chronic kidney disease management: comparison between renal transplant recipients and nontransplant patients with chronic kidney disease, Nephron Clinical practice, 107, c7, 10.1159/000105138
Kamar, 2012, Impact of post-transplant anemia on patient and graft survival rates after kidney transplantation: a meta-analysis, Clin Transpl, 26, 461, 10.1111/j.1399-0012.2011.01545.x
Singh, 2006, Correction of anemia with epoetin alfa in chronic kidney disease, The New England journal of medicine, 355, 2085, 10.1056/NEJMoa065485
Drueke, 2006, Normalization of hemoglobin level in patients with chronic kidney disease and anemia, The New England journal of medicine, 355, 2071, 10.1056/NEJMoa062276
Pfeffer, 2009, A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease, The New England journal of medicine, 361, 2019, 10.1056/NEJMoa0907845
Efstratiadis, 2008, Cardio-renal anemia syndrome, Hippokratia, 12, 11
Mudge, 2012, A randomized controlled trial of intravenous or oral iron for posttransplant anemia in kidney transplantation, Transplantation, 93, 822, 10.1097/TP.0b013e318248375a
Besarab, 1998, The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin, The New England journal of medicine, 339, 584, 10.1056/NEJM199808273390903
Streja, 2008, Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis, American journal of kidney diseases: the official journal of the National Kidney Foundation, 52, 727, 10.1053/j.ajkd.2008.05.029
Locatelli, 2013, Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement, Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association. Nephrol Dial Transplant, 28, 1346, 10.1093/ndt/gft033
Regidor, 2006, Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients, Journal of the American Society of Nephrology: JASN, 17, 1181, 10.1681/ASN.2005090997
Solomon, 2010, Erythropoietic response and outcomes in kidney disease and type 2 diabetes, The New England journal of medicine, 363, 1146, 10.1056/NEJMoa1005109
Szczech, 2008, Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes, Kidney international, 74, 791, 10.1038/ki.2008.295
Molnar, 2012, Associations of pre-transplant anemia management with post-transplant delayed graft function in kidney transplant recipients, Clin Transpl, 26, 782, 10.1111/j.1399-0012.2012.01598.x
Wagner, 2011, Endogenous erythropoietin and the association with inflammation and mortality in diabetic chronic kidney disease, Clinical journal of the American Society of Nephrology: CJASN, 6, 1573, 10.2215/CJN.00380111
Molnar, 2011, Serum erythropoietin level and mortality in kidney transplant recipients, Clinical journal of the American Society of Nephrology: CJASN, 6, 2879, 10.2215/CJN.05590611
Almond, 1994, Increased erythropoietin requirements in patients with failed renal transplants returning to a dialysis programme, Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association – European Renal Association, 9, 270
Koulouridis, 2013, Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis, American journal of kidney diseases: the official journal of the National Kidney Foundation, 61, 44, 10.1053/j.ajkd.2012.07.014
Bradbury, 2009, Evolving statistical methods to facilitate evaluation of the causal association between erythropoiesis-stimulating agent dose and mortality in nonexperimental research: strengths and limitations, American journal of kidney diseases: the official journal of the National Kidney Foundation, 54, 554, 10.1053/j.ajkd.2009.05.010
Choukroun, 2012, Correction of postkidney transplant anemia reduces progression of allograft nephropathy, Journal of the American Society of Nephrology: JASN, 23, 360, 10.1681/ASN.2011060546
Martinez, 2010, High dose epoetin beta in the first weeks following renal transplantation and delayed graft function: Results of the Neo-PDGF Study, American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 10, 1695, 10.1111/j.1600-6143.2010.03142.x
Macdougall, 2013, How important is transfusion avoidance in 2013?, Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association. Nephrol Dial Transplant, 28, 1092, 10.1093/ndt/gfs575
Kiberd, 2009, Post-transplant erythrocytosis: a disappearing phenomenon?, Clinical transplantation, 23, 800, 10.1111/j.1399-0012.2008.00947.x
Kessler, 1996, Factors predisposing to post-renal transplant erythrocytosis. A prospective matched-pair control study, Clinical nephrology, 45, 83
Gaciong, 1996, Erythropoietin production after kidney transplantation, Annals of transplantation: quarterly of the Polish Transplantation Society, 1, 29
Vlahakos, 2003, Posttransplant erythrocytosis, Kidney international, 63, 1187, 10.1046/j.1523-1755.2003.00850.x
Brox, 1998, Erythrocytosis after renal transplantation represents an abnormality of insulin-like growth factor-I and its binding proteins, Transplantation, 66, 1053, 10.1097/00007890-199810270-00015
Kiykim, 2009, Serum stem cell factor level in renal transplant recipients with posttransplant erythrocytosis, Artificial organs, 33, 1086, 10.1111/j.1525-1594.2009.00823.x
Wickre, 1983, Postrenal transplant erythrocytosis: a review of 53 patients, Kidney international, 23, 731, 10.1038/ki.1983.86
Abbud-Filho, 2007, A report of the Lisbon Conference on the care of the kidney transplant recipient, Transplantation, 83, S1, 10.1097/01.tp.0000260765.41275.e2
Hiremath, 2007, Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence, American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 7, 2350, 10.1111/j.1600-6143.2007.01928.x
Barenbrock, 1993, Therapeutic efficiency of phlebotomy in posttransplant hypertension associated with erythrocytosis, Clinical nephrology, 40, 241
Bakris, 1990, Effects of theophylline on erythropoietin production in normal subjects and in patients with erythrocytosis after renal transplantation, The New England journal of medicine, 323, 86, 10.1056/NEJM199007123230203
Zafrani, 2009, Incidence, risk factors and clinical consequences of neutropenia following kidney transplantation: a retrospective study, American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 9, 1816, 10.1111/j.1600-6143.2009.02699.x
Ojo, 2000, Long-term survival in renal transplant recipients with graft function, Kidney international, 57, 307, 10.1046/j.1523-1755.2000.00816.x
Danesi, 2004, Hematologic toxicity of immunosuppressive treatment, Transplantation proceedings, 36, 703, 10.1016/j.transproceed.2004.03.016
1996, A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group, Transplantation, 61, 1029, 10.1097/00007890-199604150-00008
Rerolle, 2007, Unexpected rate of severe leucopenia with the association of mycophenolate mofetil and valganciclovir in kidney transplant recipients, Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association – European Renal Association, 22, 671, 10.1093/ndt/gfl539
Royer, 2003, A neutropenia suggesting an interaction between valacyclovir and mycophenolate mofetil, Clinical transplantation, 17, 158, 10.1034/j.1399-0012.2003.00052.x
Walker, 2007, Leukopenia complicates cytomegalovirus prevention after renal transplantation with alemtuzumab induction, Transplantation, 83, 874, 10.1097/01.tp.0000257923.69422.4d
Zucker, 1999, Evidence that tacrolimus augments the bioavailability of mycophenolate mofetil through the inhibition of mycophenolic acid glucuronidation, Therapeutic drug monitoring, 21, 35, 10.1097/00007691-199902000-00006
Knoll, 2003, Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation, Journal of the American Society of Nephrology: JASN, 14, 2381, 10.1097/01.ASN.0000079616.71891.F5
Pelletier, 2003, The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation, Clinical transplantation, 17, 200, 10.1034/j.1399-0012.2003.00026.x
Diaz-Pedroche, 2006, Valganciclovir preemptive therapy for the prevention of cytomegalovirus disease in high-risk seropositive solid-organ transplant recipients, Transplantation, 82, 30, 10.1097/01.tp.0000225830.76907.d0
Buchler, 2003, French Thymoglobuline Pharmacovigilance Study G. Induction therapy by anti-thymocyte globulin (rabbit) in renal transplantation: a 1-yr follow-up of safety and efficacy, Clinical transplantation, 17, 539, 10.1046/j.1399-0012.2003.00102.x
Gabardi, 2012, Atovaquone versus trimethoprim-sulfamethoxazole as Pneumocystis jirovecii pneumonia prophylaxis following renal transplantation, Clinical transplantation, 26, E184, 10.1111/j.1399-0012.2012.01624.x
2009, KDIGO clinical practice guideline for the care of kidney transplant recipient, American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 9, S1
Pour-Reza-Gholi, 2005, Signs and symptoms of cytomegalovirus disease in kidney transplant recipients, Transplantation proceedings, 37, 3056, 10.1016/j.transproceed.2005.07.051
Fuchs, 2004, Cytomegalovirus-induced pancytopenia after heart transplantation, Transplantation, 78, 783, 10.1097/01.TP.0000128834.48158.9E
Razeghi, 2007, Clinical manifestation, laboratory findings, and the response of treatment in kidney transplant recipients with CMV infection, Transplantation proceedings, 39, 993, 10.1016/j.transproceed.2007.02.014
Hodson, 2013, Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients, Cochrane database of systematic reviews, 2, CD003774
Owers, 2013, Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients, Cochrane database of systematic reviews, 2, CD005133
Fishman, 2007, Cytomegalovirus in transplantation – challenging the status quo, Clin Transpl, 21, 149, 10.1111/j.1399-0012.2006.00618.x
Andrassy, 2012, Is cytomegalovirus prophylaxis dispensable in patients receiving an mTOR inhibitor-based immunosuppression? a systematic review and meta-analysis, Transplantation, 94, 1208, 10.1097/TP.0b013e3182708e56
Luppi, 2000, Bone marrow failure associated with human herpesvirus 8 infection after transplantation, The New England journal of medicine, 343, 1378, 10.1056/NEJM200011093431905
Lautenschlager, 2012, Human herpesvirus-6 infections in kidney, liver, lung, and heart transplantation: review, Transplant international: official journal of the European Society for Organ Transplantation, 25, 493, 10.1111/j.1432-2277.2012.01443.x
Hughes, 2002, 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer, Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 34, 730, 10.1086/339215
Hartmann, 2008, Management of leukopenia in kidney and pancreas transplant recipients, Clinical transplantation, 22, 822, 10.1111/j.1399-0012.2008.00893.x
Hurst, 2011, Poor outcomes associated with neutropenia after kidney transplantation: analysis of United States Renal Data System, Transplantation, 92, 36, 10.1097/TP.0b013e31821c1e70
Matsui, 2010, Mycophenolate mofetil-induced agranulocytosis in a renal transplant recipient, Clinical and experimental nephrology, 14, 637, 10.1007/s10157-010-0323-y
Minguez, 1995, Worsening of renal function in a renal transplant patient treated with granulocyte colony-stimulating factor, Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association, 10, 2166
Mourad, 2012, The role of Thymoglobulin induction in kidney transplantation: an update, Clin Transpl, 26, E450, 10.1111/ctr.12021
Bergesio, 2005, Cardiovascular risk factors in severe chronic renal failure: the role of dietary treatment, Clinical nephrology, 64, 103, 10.5414/CNP64103
Brennan, 2006, Thymoglobulin Induction Study G. Rabbit antithymocyte globulin versus basiliximab in renal transplantation, The New England journal of medicine, 355, 1967, 10.1056/NEJMoa060068
Kreis, 2004, Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal, Journal of the American Society of Nephrology: JASN, 15, 809, 10.1097/01.ASN.0000113248.59077.76
Schiffer, 2001, Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology, Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 19, 1519, 10.1200/JCO.2001.19.5.1519
Noris, 2010, Thrombotic microangiopathy after kidney transplantation, American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 10, 1517, 10.1111/j.1600-6143.2010.03156.x
Zuber, 2011, New insights into postrenal transplant hemolytic uremic syndrome, Nature reviews Nephrology, 7, 23, 10.1038/nrneph.2010.155
Bresin, 2006, Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background, Clinical journal of the American Society of Nephrology: CJASN, 1, 88, 10.2215/CJN.00050505
Ducloux, 1998, Recurrence of hemolytic-uremic syndrome in renal transplant recipients: a meta-analysis, Transplantation, 65, 1405, 10.1097/00007890-199805270-00023
Lahlou, 2000, Hemolytic uremic syndrome. Recurrence after renal transplantation. Groupe Cooperatif de l'Ile-de-France (GCIF), Medicine, 79, 90, 10.1097/00005792-200003000-00003
Nester, 2011, Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome, Clinical journal of the American Society of Nephrology: CJASN, 6, 1488, 10.2215/CJN.10181110
Zimmerhackl, 2010, Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome, The New England journal of medicine, 362, 1746, 10.1056/NEJMc1001060
Canaud, 2013, Eculizumab improves posttransplant thrombotic microangiopathy due to antiphospholipid syndrome recurrence but fails to prevent chronic vascular changes, American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 13, 2179, 10.1111/ajt.12319
Pham, 2000, Cyclosporine and tacrolimus-associated thrombotic microangiopathy, American journal of kidney diseases: the official journal of the National Kidney Foundation, 36, 844, 10.1053/ajkd.2000.17690
Sartelet, 2005, Sirolimus-induced thrombotic microangiopathy is associated with decreased expression of vascular endothelial growth factor in kidneys, American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 5, 2441, 10.1111/j.1600-6143.2005.01047.x
Pisoni, 2001, Drug-induced thrombotic microangiopathy: incidence, prevention and management, Drug safety: an international journal of medical toxicology and drug experience, 24, 491, 10.2165/00002018-200124070-00002
Ormrod, 2000, Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections, Drugs, 59, 839, 10.2165/00003495-200059040-00013
Murer, 2000, Thrombotic microangiopathy associated with parvovirus B 19 infection after renal transplantation, Journal of the American Society of Nephrology: JASN, 11, 1132, 10.1681/ASN.V1161132
Ponticelli, 2006, Thrombotic microangiopathy after kidney transplantation, Transplant international: official journal of the European Society for Organ Transplantation, 19, 789, 10.1111/j.1432-2277.2006.00354.x
Reynolds, 2003, Thrombotic microangiopathy after renal transplantation in the United States, American journal of kidney diseases: the official journal of the National Kidney Foundation, 42, 1058, 10.1016/j.ajkd.2003.07.008
Chandran, 2011, Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-kidney transplantation–a case report, Transplantation proceedings, 43, 2097, 10.1016/j.transproceed.2011.02.064
Bren, 2005, Follow-up of kidney graft recipients with cyclosporine-associated hemolytic-uremic syndrome and thrombotic microangiopathy, Transplantation proceedings, 37, 1889, 10.1016/j.transproceed.2005.02.112
Ashman, 2009, Belatacept as maintenance immunosuppression for postrenal transplant de novo drug-induced thrombotic microangiopathy, American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 9, 424, 10.1111/j.1600-6143.2008.02482.x
Weclawiak, 2010, Biological agents in kidney transplantation: belatacept is entering the field, Expert opinion on biological therapy, 10, 1501, 10.1517/14712598.2010.514901
Gross, 2010, Posttransplant lymphoproliferative diseases, Pediatric clinics of North America, 57, 481, 10.1016/j.pcl.2010.01.011
Parker, 2010, Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients - BCSH and BTS Guidelines, British journal of haematology, 149, 693, 10.1111/j.1365-2141.2010.08160.x
Bagg, 2013, Immunosuppressive and immunomodulatory therapy-associated lymphoproliferative disorders, Seminars in diagnostic pathology, 30, 102, 10.1053/j.semdp.2012.08.005
Murukesan, 2012, Managing post-transplant lymphoproliferative disorders in solid-organ transplant recipients: a review of immunosuppressant regimens, Drugs, 72, 1631, 10.2165/11635690-000000000-00000
Bollard, 2012, T-cell therapy in the treatment of post-transplant lymphoproliferative disease, Nature reviews Clinical oncology, 9, 510, 10.1038/nrclinonc.2012.111
Petz, 2005, Immune hemolysis associated with transplantation, Seminars in hematology, 42, 145, 10.1053/j.seminhematol.2005.05.017
Sokol, 2002, Posttransplant immune-mediated hemolysis, Transfusion, 42, 198, 10.1046/j.1537-2995.2002.00026.x
Ramsey, 1989, Red cell antibody problems in 1000 liver transplants, Transfusion, 29, 396, 10.1046/j.1537-2995.1989.29589284137.x
Achkar, 2011, Hemolytic anemia after kidney transplantation: a prospective analysis, Transfusion, 51, 2495, 10.1111/j.1537-2995.2011.03192.x
Karras, 2004, Groupe Cooperatif de transplantation d'Ile de F. Hemophagocytic syndrome in renal transplant recipients: report of 17 cases and review of literature, Transplantation, 77, 238, 10.1097/01.TP.0000107285.86939.37
Yorgin, 2002, Late post-transplant anemia in adult renal transplant recipients. An under-recognized problem?, 2, 429
Molnar, 2005, Anemia in kidney transplanted patients, Clinical transplantation, 19, 825, 10.1111/j.1399-0012.2005.00428.x